Back to Markets
CNContext Therapeutics Inc

Context Therapeutics Inc

CNTXNASDAQ NMS - GLOBAL MARKET
Health CarePharmaceuticals

$2.85

+0.0200 (+0.71%)

As of 05/29/26 EDT · USD

Compare
Low: $0.5200Current: $2.85High: $3.62

Key Statistics

Open

$2.83

Day High

$2.87

Day Low

$2.74

Prev. Close

$2.83

VolumeShares traded today.

544.82K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$261.86M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-6.74

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$3.62

52W LowLowest price over the past 52 weeks.

$0.5200

50D MAAverage closing price over the last 50 trading days.

$2.51

200D MAAverage closing price over the last 200 trading days.

$1.74

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+18.8%

1M

+21.8%

6M

+154.5%

YTD

+83.9%

1Y

+384.7%

About

Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. The company was developing simufilam, an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.

www.contexttherapeutics.com/

Company Facts

SectorHealth Care
IndustryPharmaceuticals
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade CNTX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.